Stephen Hoge, President of Moderna, Inc. (NASDAQ:MRNA), filed a Form 4 on November 18, 2026, disclosing stock option exercises, open-market sales, and a charitable gift of common stock on November 16 and 17, 2026.

Key Highlights

  • Option exercises: Hoge exercised stock options covering 76,453 shares on November 16 and 76,452 shares on November 17, both at an exercise price of $12.21 per share, fully exhausting the options, which had an expiration date of February 23, 2027.
  • Open-market sales: Hoge disposed of 39,160 shares on November 16 at a weighted average price of $219.66, and sold a combined 39,215 shares on November 17 across three tranches at weighted average prices of $211.45, $212.57, and $214.19.
  • Charitable gift: On November 16, Hoge disposed of 400,000 shares via a bona fide charitable gift at $0 consideration, according to the filing.
  • 10b5-1 plan: All option exercises and sales were effected pursuant to a Rule 10b5-1 trading plan adopted on June 15, 2026, the filing stated.
  • Remaining direct ownership: Following all reported transactions, Hoge directly owned 1,311,095 shares of common stock, per the filing.
  • Indirect holdings: The filing also reported 4,116 shares held indirectly through Valhalla, LLC, and 151,933 shares held indirectly through a trust for the benefit of Hoge's spouse and children.

Transaction Details: Exercises, Sales, and a Charitable Disposition

According to the filing, Hoge exercised fully vested stock options on two consecutive days. On November 16, 2026, he acquired 76,453 shares via option exercise at $12.21, bringing his direct holdings to 1,713,018 shares. He then sold 39,160 shares at a weighted average price of $219.66 (with individual transaction prices ranging from $219.54 to $220.53), reducing his direct position to 1,673,858 shares. Later that same day, he gifted 400,000 shares to charity at $0, reducing his direct holdings further to 1,273,858 shares.

On November 17, 2026, Hoge exercised a second tranche of 76,452 options at $12.21, bringing direct holdings to 1,350,310 shares. He then conducted three separate sales: 33,976 shares at a weighted average of $211.45 (range $211.41 to $212.17), 5,082 shares at a weighted average of $212.57 (range $212.50 to $213.25), and 157 shares at a weighted average of $214.19 (range $213.92 to $214.50). Following these transactions, his direct beneficial ownership stood at 1,311,095 shares, the filing disclosed.

The filing noted that the 151,933 shares held indirectly through a trust are for the benefit of Hoge's spouse and children, with his spouse serving as trustee. The filing stated that Hoge "disclaims Section 16 beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any." All transactions were signed by James Dillon as Attorney-in-Fact on November 18, 2026.

What Was Disclosed

Stephen Hoge, President of Moderna, Inc., reported the exercise of stock options totaling 152,905 shares, the sale of 78,375 shares, and a charitable gift of 400,000 shares on November 16 and 17, 2026, all under a pre-established Rule 10b5-1 trading plan.